Cargando…
Image-Guided Cancer Nanomedicine
Multifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197060/ https://www.ncbi.nlm.nih.gov/pubmed/30364459 http://dx.doi.org/10.3390/jimaging4010018 |
_version_ | 1783364681340026880 |
---|---|
author | Kim, Dong-Hyun |
author_facet | Kim, Dong-Hyun |
author_sort | Kim, Dong-Hyun |
collection | PubMed |
description | Multifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive and active targeting of nanotherapeutics along with the toxicity of nanoparticles has been a major problem in nanomedicine. Recently, image-guided nanomedicine, which can deliver nanoparticles locally using non-invasive imaging and interventional oncology techniques, has been paid attention as a new opportunity of nanomedicine. This short review will discuss the existing challenges in nanomedicine and describe the prospects for future image-guided nanomedicine. |
format | Online Article Text |
id | pubmed-6197060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-61970602018-10-22 Image-Guided Cancer Nanomedicine Kim, Dong-Hyun J Imaging Article Multifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive and active targeting of nanotherapeutics along with the toxicity of nanoparticles has been a major problem in nanomedicine. Recently, image-guided nanomedicine, which can deliver nanoparticles locally using non-invasive imaging and interventional oncology techniques, has been paid attention as a new opportunity of nanomedicine. This short review will discuss the existing challenges in nanomedicine and describe the prospects for future image-guided nanomedicine. 2018-01-11 2018 /pmc/articles/PMC6197060/ /pubmed/30364459 http://dx.doi.org/10.3390/jimaging4010018 Text en http://creativecommons.org/licenses/by/4.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Dong-Hyun Image-Guided Cancer Nanomedicine |
title | Image-Guided Cancer Nanomedicine |
title_full | Image-Guided Cancer Nanomedicine |
title_fullStr | Image-Guided Cancer Nanomedicine |
title_full_unstemmed | Image-Guided Cancer Nanomedicine |
title_short | Image-Guided Cancer Nanomedicine |
title_sort | image-guided cancer nanomedicine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197060/ https://www.ncbi.nlm.nih.gov/pubmed/30364459 http://dx.doi.org/10.3390/jimaging4010018 |
work_keys_str_mv | AT kimdonghyun imageguidedcancernanomedicine |